Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Intervalo de ano de publicação
1.
Anim Reprod Sci ; 171: 121-8, 2016 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-27346588

RESUMO

The present study reports the effect of shortening the prefreezing equilibration time with glycerol on the quality of frozen-thawed ejaculated sperm from four Mediterranean mountain ungulates: Cantabrian chamois (Rupicapra pyrenaica), Iberian ibex (Capra pyrenaica), mouflon (Ovis musimon) and aoudad (Ammotragus lervia). Ejaculated sperm from these species were divided into two aliquots. One was diluted with either a Tris-citric acid-glucose based medium (TCG-glycerol; for chamois and ibex sperm) or a Tris-TES-glucose-based medium (TTG-glycerol; for mouflon and aoudad sperm), and maintained at 5°C for 3h prior to freezing. The other aliquot was diluted with either TCG (chamois and ibex sperm) or TTG (mouflon and aoudad sperm) and maintained at 5°C for 1h before adding glycerol (final concentration 5%). After a 15min equilibration period in the presence of glycerol, the samples were frozen. For the ibex, there was enhanced (P<0.05) sperm viability and acrosome integrity after the 3h as compared with the 15min equilibration time. For the chamois, subjective sperm motility and cell membrane functional integrity were less (P<0.05) following 15min of equilibration. In the mouflon, progressive sperm motility and acrosome integrity was less (P<0.05) when the equilibration time was reduced to 15min. For the aoudad, the majority of sperm variables measured were more desirable after the 3h equilibration time. The freezing-thawing processes reduced the sperm head size in all the species studied; however, the equilibration time further affected the frozen-thawed sperm head variables in a species-dependent fashion. While the equilibration time for chamois sperm might be shortened, this appears not to be the case for all ungulates.


Assuntos
Criopreservação/veterinária , Crioprotetores/farmacologia , Glicerol/farmacologia , Preservação do Sêmen/veterinária , Ovinos/fisiologia , Animais , Criopreservação/métodos , Crioprotetores/administração & dosagem , Glicerol/administração & dosagem , Masculino , Preservação do Sêmen/métodos , Ovinos/classificação , Especificidade da Espécie , Motilidade dos Espermatozoides , Temperatura
2.
J Hum Hypertens ; 28(9): 535-42, 2014 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-24430701

RESUMO

Overweight clusters with high blood pressure (BP), but the independent contribution of both risk factors remains insufficiently documented. In a prospective population study involving 8467 participants (mean age 54.6 years; 47.0% women) randomly recruited from 10 populations, we studied the contribution of body mass index (BMI) to risk over and beyond BP, taking advantage of the superiority of ambulatory over conventional BP. Over 10.6 years (median), 1271 participants (15.0%) died and 1092 (12.9%), 637 (7.5%) and 443 (5.2%) experienced a fatal or nonfatal cardiovascular, cardiac or cerebrovascular event. Adjusted for sex and age, low BMI (<20.7 kg m(-2)) predicted death (hazard ratio (HR) vs average risk, 1.52; P<0.0001) and high BMI (> or = 30.9 kg m(-2)) predicted the cardiovascular end point (HR, 1.27; P=0.006). With adjustments including 24-h systolic BP, these HRs were 1.50 (P<0.001) and 0.98 (P=0.91), respectively. Across quartiles of the BMI distribution, 24-h and nighttime systolic BP predicted every end point (1.13 < or = standardized HR < or = 1.67; 0.046 < or = P<0.0001). The interaction between systolic BP and BMI was nonsignificant (P > or = .22). Excluding smokers removed the contribution of BMI categories to the prediction of mortality. In conclusion, BMI only adds to BP in risk stratification for mortality but not for cardiovascular outcomes. Smoking probably explains the association between increased mortality and low BMI.


Assuntos
Monitorização Ambulatorial da Pressão Arterial , Pressão Sanguínea , Índice de Massa Corporal , Hipertensão/diagnóstico , Hipertensão/etnologia , Obesidade/diagnóstico , Obesidade/etnologia , Adulto , Idoso , Anti-Hipertensivos/uso terapêutico , Ásia/epidemiologia , Pressão Sanguínea/efeitos dos fármacos , Europa (Continente)/epidemiologia , Feminino , Humanos , Hipertensão/tratamento farmacológico , Hipertensão/mortalidade , Hipertensão/fisiopatologia , Incidência , Masculino , Pessoa de Meia-Idade , Obesidade/mortalidade , Obesidade/fisiopatologia , Valor Preditivo dos Testes , Prognóstico , Estudos Prospectivos , Medição de Risco , Fatores de Risco , Fumar/efeitos adversos , Fumar/mortalidade , América do Sul/epidemiologia , Fatores de Tempo
3.
São Paulo; Santos; 3 ed; 1996. 80 p. graf, ilus, tab.
Monografia em Português | Sec. Munic. Saúde SP, AHM-Acervo, TATUAPE-Acervo | ID: sms-5668
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA